HIV protease inhibitors and atherosclerosis

Por Hui, David Y.
Publicado em 2003

Intimal Hyperplasia in Murine Models

Por Hui, David Y.
Publicado em 2008

Phospholipase A(2) enzymes in metabolic and cardiovascular diseases

Por Hui, David Y.
Publicado em 2012

Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease

Por Hui, David Y.
Publicado no Curr Opin Lipidol (2016)

The good side of cholesterol: a requirement for maintenance of intestinal integrity(1)

Por Hui, David Y.
Publicado no J Lipid Res (2017)

Group 1B phospholipase A(2) deficiency protects against diet-induced hyperlipidemia in mice

Por Hollie, Norris I., Hui, David Y.
Publicado em 2011

Physiological role of hepatic NPC1L1 in human cholesterol and lipoprotein metabolism: New perspectives and open questions(1)

Por Howles, Philip N., Hui, David Y.
Publicado em 2012

Phosphatidylinositol turnover in mitogen-activated lymphocytes. Suppression by low-density lipoproteins

Por Hui, David Y., Harmony, Judith A. K.
Publicado em 1980

Apolipoprotein E Inhibition of Vascular Hyperplasia and Neointima Formation Requires Inducible Nitric Oxide Synthase

Por Moore, Zachary W. Q., Hui, David Y.
Publicado em 2005

Apolipoprotein E Inhibits Toll-like Receptor (TLR)-3 and TLR-4 Mediated Macrophage Activation through Distinct Mechanisms

Por ZHU, Yanjuan, KODVAWALA, Ahmer, HUI, David Y.
Publicado em 2010

Mixed Lineage Kinase 3 Deficiency Promotes Neointima Formation through Increased Activation of the RhoA Pathway in Vascular Smooth Muscle Cells

Por Gadang, Vidya, Konaniah, Eddy, Hui, David Y., Jaeschke, Anja
Publicado em 2014

Group 1B Phospholipase A2 Inactivation Suppresses Atherosclerosis and Metabolic Diseases in LDL Receptor-deficient Mice

Por Hollie, Norris I., Konaniah, Eddy S., Goodin, Colleen, Hui, David Y.
Publicado em 2014

Apolipoprotein E Inhibits Neointimal Hyperplasia after Arterial Injury in Mice

Por Zhu, Binghua, Kuhel, David G., Witte, David P., Hui, David Y.
Publicado em 2000

Use of NBD-cholesterol to identify a minor but NPC1L1-independent cholesterol absorption pathway in mouse intestine

Por Adams, Michelle R., Konaniah, Eddy, Cash, James G., Hui, David Y.
Publicado em 2011

Pancreatic acinar cell-specific over-expression of group 1B phospholipase A(2) exacerbates diet-induced obesity and insulin resistance in mice

Por Cash, James G, Kuhel, David G, Goodin, Colleen, Hui, David Y
Publicado em 2010

LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes

Por Hamlin, Allyson N., Basford, Joshua E., Jaeschke, Anja, Hui, David Y.
Publicado no J Biol Chem (2016)

Vascular Apolipoprotein E Expression and Recruitment from Circulation to Modulate Smooth Muscle Cell Response to Endothelial Denudation

Por Moore, Zachary W.Q., Zhu, Binghua, Kuhel, David G., Hui, David Y.
Publicado em 2004

Histone Deacetylases and Cardiometabolic Diseases

Por Yiew, Kan Hui, Chatterjee, Tapan K., Hui, David Y., Weintraub, Neal L.
Publicado no Arterioscler Thromb Vasc Biol (2015)

Carboxyl ester lipase activity in milk prevents fat-derived intestinal injury in neonatal mice

Por HOWLES, PHILIP N., STEMMERMAN, GRANT N., FENOGLIO-PREISER, CECILIA M., HUI, DAVID Y.
Publicado em 1999

Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice

Por Liu, Min, Kuhel, David G., Shen, Ling, Hui, David Y., Woods, Stephen C.
Publicado em 2012